Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 424-429

  Myers, Russell B ^a   Oelschlager, Denise ^a   Manne, Upender ^a   Coan, Patricia N ^b   Weiss, Heidi ^c   Grizzle, William E ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; TESTOSTERONE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTO ONCOGENE;

ADENOCARCINOMA; ANDROGENS; ANIMALS; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; ORCHIECTOMY; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TRANSFORMING GROWTH FACTOR ALPHA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033010379     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<424::AID-IJC16>3.0.CO;2-B     Document Type: Article

References (29)

1. ARNOLD, M.M., SRIVASTAVA, S., FREDENBURGH, J., STOCKARD, C.R., MYERS, R.B. and GRIZZLE, W.E., Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens. Biotechnol. Histochem., 71, 224-230 (1996).
2. COFFEY, D.S., The molecular biology of the prostate. In: H. Lepor and R.K. Lawson (eds.), Prostate diseases, pp. 28-56, W.B. Saunders, Philadelphia (1993).
3. CULIG, Z., HOBISCH, A., CRONAUER, M.V., RADMAYR, C., HITTMAIR, A., ZHANG, J., THURNER, M., BARTSCH, G. and KLOCKER, H., Regulation of prostatic growth and function by peptide growth factors. Prostate, 28, 392-405 (1996).
4. GLEAVE, M., HSIEH, J.T., GAO, C., VON ESCHENBACH, A.C. and CHUNG, L.W.K., Acceleration of human prostate cancer in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51, 3753-3761 (1991).
5. HARPER, M.E., GODDARD, E., GLYNNE-JONES, E., WILSON, D.W., PRICE-THOMAS, M., PEELING, W.B. and GRIFFITHS, K., An immunohistochemical analysis of TGFα expression in benign and malignant prostatic tumors. Prostate, 23, 9-23 (1993).
6. HUGGINS, C. and HODGES, C.V., Studies on prostatic cancer 1. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1, 293-297 (1941).
7. KOKONTIS, J.M. and LIAO, S., Molecular action of androgen in the normal and neoplastic prostate. Vitamins Hormones, 55, 219-308 (1999).
8. LIU, X.H., WILEY, H.S. and MEIKLE, A.W., Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J. clin. Endocrinol. Metab., 77, 1472-1478 (1993).
9. LU, S., TSAI, S.Y. and TSAI, M.J., Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4 and CKI p16 genes. Cancer Res., 57, 4511-4516 (1997).
10. MARGOLIS, B., RHEE, S.G., FELDER, S., MERVIC, M., LYALL, R., LEVITZKI, A., ULLRICH, A., ZIBERSTEIN, A. and SCHLESSINGER, J., EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell, 57, 1101-1107 (1989).
11. MAYGARDEN, S.J., STROM, S. and WARE, J.L., Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia and benign hyperplasia. Arch. Pathol. Lab. Med., 166, 269-273 (1992).
12. MURPHY, L.J., MURPHY, L.C. and FRIESEN, H.G., Estrogen induces insulin like growth factor-1 expression in the rat uterus. Mol. Endocrinol., 1, 445-450 (1987).
13. MYERS, R.B. and GRIZZLE, W.E., Biomarker expression in prostatic intraepithelial neoplasia. Europ. Urol., 30, 153-166 (1996).
14. MYERS, R.B., LAMPEJO, O., HERRERA, G.A., SRIVASTAVA, S., OELSCHLAGER, D., BROWN, D.A., WATERBOR, J.W. and GRIZZLE, W.E., TGFα expression is a relatively late event in the progression of prostatic adenocarcinoma. J. Urol. Pathol., 3, 195-204 (1995).
15. MYERS, R.B., OELSCHLAGER, D.K., COAN, P.N., FROST, A.R., WEISS, H.L., MANNE, U., PRETLOW, T.G. and GRIZZLE, W.E., Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostalic adenocarcinoma. J. Urol., 161, 945-949 (1999).
16. erbB-2 and c-erbB-2 mRNA in the prostatic cell line LNCaP. J. Steroid Biochem. Mol. Biol., 59, 441-447 (1996).
17. erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. nat. Cancer Inst., 86, 1140-1145 (1994).
18. NAGABHUSHAN, M., MILLER, C.M., PRETLOW, T.P., GIACONIA, J.M., EDGEHOUSE, N.L., SCHWARTZ, S., KUNG. H.J., DE VERE WHITE, R.W., GUMERLOCK, P.H., RESNICK, M.I., AMINI, S.B. and PRETLOW, T.G., CWR22: the first human prostate xenograft with strongly androgen dependent and relapsed strains both in vivo and in soft agar. Cancer Res., 56, 3042-3046 (1996).
19. NELSON, K.G., TAKAHASHI, T., LEE, D.C., LEUTTEKE, N.C., BESSERT, N.L., ROSS, K., FITZMAN, B.E. and MCLACHLAN, J.A., Transforming growth factor α is a potential mediator of estrogen action in the mouse uterus. Endocrinology, 131, 1657-1664 (1992).
20. SADASIVAN, R., MORGAN, R., JENNINGS, S., AUSTENFELD, M., VAN VELDHUIZEN. P., STEPHENS. R. and NOBLE, M., Overexpression of HER-2/NEU may bean indicator of poor prognosis in prostate cancer. J. Urol., 150, 126-131 (1993).
21. SATO, N., GLEAVE, M.E., BRUCHOVSKY, N., RENNIE, P.S., GOLDENBERG, S.L., LANGE, P. and SULLIVAN, L.D., Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumor model. J. Steroid Biochem. mol. Biol., 58, 139-146 (1996).
22. SCHER, H.I., SARKIS, A, REUTER, V., COHEN, D., NETTO, G., PETRYLAK, D., LIANES, P., FUKS, Z., MENDELSOHN, J. and CORDON-CARDO, C., Changing pattern of the expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin. Cancer Res., 1, 545-550 (1995).
23. SCHUURMANS, A.L.G., BOLT, J., VELDSCHOLTE, J. and MULDER, E., Regulation of growth of LNCaP prostate tumor cells by growth factors and steroid hormones. J. Steroid. Biochem. mol. Biol., 40, 193-197 (1991).
24. SCHUURMANS, A.L.G., BOLT, J., VOORHORST, M.M., BLANKENSTEIN, R.A. and MULDER, E., Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Int. J. Cancer, 42, 917-922 (1988).
25. SMITH, C.L., Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod., 58, 627-632 (1998).
26. TAN, J. AND 12 OTHERS, Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol. Endocrinol., 11, 450-459 (1997).
27. WAINSTEIN, M.A. AND 12 OTHERS, CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res., 54, 6049-6052 (1994).
28. WARE, J.L., MAYGARDEN, S.J., KOONTZ, W.W. and STROM, S.C., Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum. Pathol., 22, 254-258 (1991).
29. ZHAU, H.E., WAN, D.S., ZHOU, J., MILLER, G. and VON ESCHENBACH, A.C., Expression of c-erbB-2/neu proto-oncogene in human prostatic cancer tissues and cell lines. Mol. Carcinogenesis, 5, 320-327 (1992).